Literature DB >> 32383089

Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells.

Walaa Alshafie1, Yingzhou Edward Pan2,3, Hans-Jürgen Kreienkamp3, Thomas Stroh4.   

Abstract

BACKGROUND: Somatostatin (SOM) receptor subtype 2 (SSTR2) is the major receptor subtype mediating SOM effects throughout the neuraxis. We previously demonstrated that the non-selective agonist [D-Trp8]-SOM induces intracellular sequestration of SSTR2, whereas this receptor is maintained at the cell surface after treatment with the SSTR2-selective agonist L-779,976 in cells co-expressing SSTR2 and SSTR5. METHODS AND
RESULTS: In this study, we knocked-out SSTR5 in AtT20 cells endogenously expressing both SSTR2 and SSTR5 and used immuno-labeling and confocal microscopy to investigate the effect of SSTR5 on regulation of SSTR2 trafficking. Our results indicate that unlike [D-Trp8]-SOM-induced intracellular sequestration, L-779,976 stimulation results in the maintenance of SSTR2 at the cell surface regardless of whether SSTR5 is present or not. We then examined the trafficking pathways of SSTR2 upon stimulation by either agonist. We found that both [D-Trp8]-SOM and L-779,976 induce SSTR2 internalization via transferrin-positive vesicles. However, SSTR2 internalized upon L-779,976 treatment undergoes rapid recycling to the plasma membrane, whereas receptors internalized by [D-Trp8]-SOM recycle slowly after washout of the agonist. Furthermore, [D-Trp8]-SOM stimulation induces degradation of a fraction of internalized SSTR2 whereas L-779,976-dependent, rapid SSTR2 recycling appears to protect internalized SSTR2 from degradation. In addition, Octreotide which has preferential SSTR2 affinity, induced differential effects on both SSTR2 trafficking and degradation.
CONCLUSION: Our results indicate that the biased agonistic property of L-779,976 protects against SSTR2 surface depletion by rapidly initiating SSTR2 recycling while SSTR5 does not regulate L-779-976-dependent SSTR2 trafficking.

Entities:  

Keywords:  Intracellular trafficking; Recycling; SSTR2; SSTR5; Somatostatin

Mesh:

Substances:

Year:  2020        PMID: 32383089     DOI: 10.1007/s12020-020-02329-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

1.  Selective regulation of endogenous G protein-coupled receptors by arrestins in HEK293 cells.

Authors:  S J Mundell; J L Benovic
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

2.  Beta-arrestin is involved in the desensitization but not in the internalization of the somatostatin receptor 2A expressed in CHO cells.

Authors:  Sabrina Brasselet; Stéphanie Guillen; Jean-Pierre Vincent; Jean Mazella
Journal:  FEBS Lett       Date:  2002-04-10       Impact factor: 4.124

Review 3.  Regulation and function of somatostatin receptors.

Authors:  Gisela Olias; Cécile Viollet; Heike Kusserow; Jacques Epelbaum; Wolfgang Meyerhof
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

4.  Activated somatostatin type 2 receptors traffic in vivo in central neurons from dendrites to the trans Golgi before recycling.

Authors:  Zsolt Csaba; Benjamin Lelouvier; Cécile Viollet; Vincent El Ghouzzi; Kiyoko Toyama; Catherine Videau; Véronique Bernard; Pascal Dournaud
Journal:  Traffic       Date:  2007-05-22       Impact factor: 6.215

5.  Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.

Authors:  Nadder Sharif; Louis Gendron; Julia Wowchuk; Philippe Sarret; Jean Mazella; Alain Beaudet; Thomas Stroh
Journal:  Endocrinology       Date:  2007-02-01       Impact factor: 4.736

Review 6.  The pathophysiological consequences of somatostatin receptor internalization and resistance.

Authors:  Leo J Hofland; Steven W J Lamberts
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

Review 7.  Cellular biology of somatostatin receptors.

Authors:  Z Csaba; P Dournaud
Journal:  Neuropeptides       Date:  2001-02       Impact factor: 3.286

8.  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Authors:  P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; R Guillemin
Journal:  Science       Date:  1973-01-05       Impact factor: 47.728

9.  Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.

Authors:  Giovanni Tulipano; Ralf Stumm; Manuela Pfeiffer; Hans-Jürgen Kreienkamp; Volker Höllt; Stefan Schulz
Journal:  J Biol Chem       Date:  2004-03-04       Impact factor: 5.157

10.  Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.

Authors:  Sarah Lesche; Diana Lehmann; Falko Nagel; Herbert A Schmid; Stefan Schulz
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.